RxDoctor Payments Data

Taylor Benson, APRN

Primary Care · Burleson, TXNPI 1831704733

Payments from drug & device makers

$1,692in general payments, 2019–2025

Across 90 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$262
  • Novo Nordisk$219
  • Biohaven Pharmaceutical Holding Company Ltd.$158
  • Pfizer$131
  • AbbVie$115
  • AstraZeneca$105
  • plus $701 from 20 others

What the payments were for

  • Food & beverage$1,692100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,692 in reported general payments places this provider in the 80th percentile of 563 primary care providers in Texas.

See all primary care providers in Texas

Medicare billing

Part B allowed, 2024
$26,795
Medicare patients
103
Services billed
343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$43,040
JardianceEmpagliflozin25$19,586
TrulicityDulaglutide13$18,807
MounjaroTirzepatide15$15,591
Tresiba Flextouch U-100Insulin Degludec12$6,537
Albuterol Sulfate HfaAlbuterol Sulfate42$1,327
Levothyroxine Sodium111$1,006
Atorvastatin Calcium128$987
Bupropion XlBupropion Hcl33$811
Gabapentin42$761
Omeprazole33$610
Losartan Potassium57$550
Metoprolol Succinate46$542
Lisinopril57$496
Testosterone Cypionate13$480

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$219$43,04042 claims
Lilly USA, LLCTrulicity, Mounjaro$262$34,39828 claims
Boehringer IngelheimJardiance$56$19,58625 claims
Almatica Pharma LLCSertraline Hcl$23$30026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 563 primary care providers in Texas.

Other primary care in Burleson

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →